CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Fabrizio Schifano

OPENALEX: A5078706372↗ORCID: 0000-0002-4178-5401↗

Affiliations

Organizations

St George's Hospitalauthorship · GB St George's, University of Londonauthorship · GB University of Hertfordshireauthorship · GB University of Londonauthorship · GB

Public evidence

3 connected articles

Health-Related Quality of Life in Previous Versus Current Opiate Users Receiving HCV Therapy: Registry-Based Evidence.2026 · Europe PMC Drugs Used in "Chemsex"/Sexualized Drug Behaviour-Overview of the Related Clinical Psychopharmacological Issues.2025 · Europe PMC Is the Urine Cannabinoid Level Measured via a Commercial Point-of-Care Semiquantitative Immunoassay a Cannabis Withdrawal Syndrome Severity Predictor?2020 · Europe PMC

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Fabrizio Schifano - Medical Cannabis Research Engine